GENNEX LABORATORIES
|
GENNEX LABORATORIES Last 5 Year Balance Sheet History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
EQUITY AND LIABILITIES | |||||
Share Capital | ₹23 Cr | ₹18 Cr | ₹13 Cr | ₹13 Cr | ₹13 Cr |
Equity - Authorised | ₹25 Cr | ₹20 Cr | ₹20 Cr | ₹16 Cr | ₹16 Cr |
Equity - Issued | ₹24 Cr | ₹19 Cr | ₹13 Cr | ₹13 Cr | ₹13 Cr |
Equity Paid Up | ₹23 Cr | ₹18 Cr | ₹13 Cr | ₹13 Cr | ₹13 Cr |
Equity Shares Forfeited | - | - | - | - | - |
Adjustments to Equity | - | ₹0.36 Cr | - | - | - |
Preference Capital Paid Up | - | - | - | - | - |
Face Value | ₹1.00 | ₹1.00 | ₹1.00 | ₹1.00 | ₹1.00 |
Share Warrants & Outstandings | ₹5.72 Cr | - | - | - | - |
Total Reserves | ₹142 Cr | ₹62 Cr | ₹31 Cr | ₹27 Cr | ₹23 Cr |
Securities Premium | ₹100 Cr | ₹31 Cr | ₹6.00 Cr | ₹6.00 Cr | ₹6.00 Cr |
Capital Reserves | ₹0.96 Cr | ₹0.73 Cr | ₹0.73 Cr | ₹0.73 Cr | ₹0.73 Cr |
Profit & Loss Account Balance | ₹40 Cr | ₹30 Cr | ₹24 Cr | ₹20 Cr | ₹16 Cr |
General Reserves | ₹0.72 Cr | ₹0.72 Cr | ₹0.72 Cr | ₹0.72 Cr | ₹0.72 Cr |
Other Reserves | ₹0.06 Cr | ₹0.06 Cr | ₹-0.12 Cr | ₹-0.12 Cr | ₹-0.12 Cr |
Reserve excluding Revaluation Reserve | ₹142 Cr | ₹62 Cr | ₹31 Cr | ₹27 Cr | ₹23 Cr |
Revaluation reserve | - | - | - | - | - |
Shareholder's Funds | ₹170 Cr | ₹80 Cr | ₹44 Cr | ₹40 Cr | ₹36 Cr |
Minority Interest | ₹6.08 Cr | ₹6.17 Cr | - | - | - |
Long-Term Borrowings | - | - | - | - | - |
Secured Loans | ₹13 Cr | ₹16 Cr | - | - | - |
Non Convertible Debentures | - | - | - | - | - |
Converible Debentures & Bonds | - | - | - | - | - |
Packing Credit - Bank | - | - | - | - | - |
Inter Corporate & Security Deposit | - | - | - | - | - |
Term Loans - Banks | ₹13 Cr | ₹16 Cr | - | - | - |
Term Loans - Institutions | - | - | - | - | - |
Other Secured | - | - | - | - | - |
Unsecured Loans | - | - | - | - | - |
Fixed Deposits - Public | - | - | - | - | - |
Loans and advances from subsidiaries | - | - | - | - | - |
Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
Foreign Currency Convertible Notes | - | - | - | - | - |
Long Term Loan in Foreign Currency | - | - | - | - | - |
Loans - Banks | - | - | - | - | - |
Loans - Govt. | - | - | - | - | - |
Loans - Others | - | - | - | - | - |
Other Unsecured Loan | - | - | - | - | - |
Deferred Tax Assets / Liabilities | ₹-0.23 Cr | ₹-0.14 Cr | ₹0.00 Cr | ₹0.15 Cr | ₹0.40 Cr |
Deferred Tax Assets | ₹0.63 Cr | ₹0.53 Cr | ₹0.51 Cr | ₹0.43 Cr | ₹0.35 Cr |
Deferred Tax Liability | ₹0.40 Cr | ₹0.39 Cr | ₹0.51 Cr | ₹0.58 Cr | ₹0.75 Cr |
Other Long Term Liabilities | - | - | - | ₹0.02 Cr | ₹0.02 Cr |
Long Term Trade Payables | - | - | - | - | - |
Long Term Provisions | - | - | - | - | - |
Total Non-Current Liabilities | ₹13 Cr | ₹16 Cr | ₹0.00 Cr | ₹0.17 Cr | ₹0.41 Cr |
Current Liabilities | - | - | - | - | - |
Trade Payables | ₹15 Cr | ₹7.08 Cr | ₹7.74 Cr | ₹5.95 Cr | ₹8.13 Cr |
Sundry Creditors | ₹15 Cr | ₹7.08 Cr | ₹7.74 Cr | ₹5.95 Cr | ₹8.13 Cr |
Acceptances | - | - | - | - | - |
Due to Subsidiaries- Trade Payables | - | - | - | - | - |
Other Current Liabilities | ₹14 Cr | ₹17 Cr | ₹3.63 Cr | ₹3.29 Cr | ₹5.33 Cr |
Bank Overdraft / Short term credit | - | - | - | - | - |
Advances received from customers | ₹8.32 Cr | ₹12 Cr | ₹0.16 Cr | ₹0.37 Cr | ₹1.84 Cr |
Interest Accrued But Not Due | - | - | - | - | - |
Share Application Money | - | - | - | - | - |
Current maturity of Debentures & Bonds | - | - | - | - | - |
Current maturity - Others | - | - | - | - | - |
Other Liabilities | ₹5.37 Cr | ₹5.79 Cr | ₹3.47 Cr | ₹2.92 Cr | ₹3.49 Cr |
Short Term Borrowings | ₹5.72 Cr | ₹1.05 Cr | ₹10 Cr | ₹7.36 Cr | ₹4.98 Cr |
Secured ST Loans repayable on Demands | ₹5.72 Cr | ₹1.05 Cr | ₹10 Cr | ₹7.36 Cr | ₹4.98 Cr |
Working Capital Loans- Sec | ₹2.37 Cr | ₹0.07 Cr | ₹8.48 Cr | ₹2.07 Cr | ₹4.88 Cr |
Buyers Credits - Unsec | - | - | - | - | - |
Commercial Borrowings- Unsec | - | - | - | - | - |
Other Unsecured Loans | ₹-2.37 Cr | ₹-0.07 Cr | ₹-8.48 Cr | ₹-2.07 Cr | ₹-4.88 Cr |
Short Term Provisions | ₹5.71 Cr | ₹3.99 Cr | ₹2.71 Cr | ₹2.43 Cr | ₹2.42 Cr |
Proposed Equity Dividend | - | - | - | - | - |
Provision for Corporate Dividend Tax | - | - | - | - | - |
Provision for Tax | ₹5.26 Cr | ₹3.38 Cr | ₹2.08 Cr | ₹1.87 Cr | ₹2.14 Cr |
Provision for post retirement benefits | - | - | - | - | - |
Preference Dividend | - | - | - | - | - |
Other Provisions | ₹0.45 Cr | ₹0.61 Cr | ₹0.63 Cr | ₹0.56 Cr | ₹0.28 Cr |
Total Current Liabilities | ₹40 Cr | ₹30 Cr | ₹24 Cr | ₹19 Cr | ₹21 Cr |
Total Liabilities | ₹230 Cr | ₹132 Cr | ₹68 Cr | ₹59 Cr | ₹57 Cr |
ASSETS | |||||
Gross Block | ₹76 Cr | ₹92 Cr | ₹31 Cr | ₹30 Cr | ₹30 Cr |
Less: Accumulated Depreciation | ₹21 Cr | ₹18 Cr | ₹17 Cr | ₹16 Cr | ₹15 Cr |
Less: Impairment of Assets | - | - | - | - | - |
Net Block | ₹56 Cr | ₹74 Cr | ₹14 Cr | ₹14 Cr | ₹15 Cr |
Lease Adjustment A/c | - | - | - | - | - |
Capital Work in Progress | ₹2.33 Cr | ₹0.02 Cr | - | - | - |
Non Current Investments | ₹0.01 Cr | ₹0.01 Cr | ₹6.83 Cr | ₹6.83 Cr | ₹6.83 Cr |
Long Term Investment | ₹0.01 Cr | ₹0.01 Cr | ₹6.83 Cr | ₹6.83 Cr | ₹6.83 Cr |
Quoted | - | - | - | - | - |
Unquoted | ₹0.01 Cr | ₹0.01 Cr | ₹6.83 Cr | ₹6.83 Cr | ₹6.83 Cr |
Long Term Loans & Advances | ₹0.88 Cr | ₹0.65 Cr | ₹0.32 Cr | ₹1.57 Cr | ₹0.22 Cr |
Other Non Current Assets | - | - | - | - | - |
Total Non-Current Assets | ₹68 Cr | ₹83 Cr | ₹21 Cr | ₹23 Cr | ₹22 Cr |
Current Assets Loans & Advances | - | - | - | - | - |
Currents Investments | - | - | - | - | - |
Quoted | - | - | - | - | - |
Unquoted | - | - | - | - | - |
Inventories | ₹25 Cr | ₹16 Cr | ₹7.74 Cr | ₹5.02 Cr | ₹7.44 Cr |
Raw Materials | ₹3.18 Cr | ₹2.58 Cr | ₹1.96 Cr | ₹1.28 Cr | ₹2.09 Cr |
Work-in Progress | ₹10 Cr | ₹5.24 Cr | ₹4.28 Cr | ₹2.46 Cr | ₹1.90 Cr |
Finished Goods | ₹11 Cr | ₹7.19 Cr | ₹1.15 Cr | ₹1.07 Cr | ₹3.15 Cr |
Packing Materials | ₹0.08 Cr | ₹0.10 Cr | ₹0.05 Cr | ₹0.11 Cr | ₹0.08 Cr |
Stores  and Spare | ₹0.42 Cr | ₹0.57 Cr | ₹0.27 Cr | ₹0.09 Cr | ₹0.17 Cr |
Other Inventory | ₹0.04 Cr | ₹0.02 Cr | ₹0.02 Cr | ₹0.02 Cr | ₹0.05 Cr |
Sundry Debtors | ₹18 Cr | ₹9.42 Cr | ₹11 Cr | ₹7.66 Cr | ₹6.28 Cr |
Debtors more than Six months | ₹1.90 Cr | ₹1.02 Cr | ₹1.50 Cr | - | - |
Debtors Others | ₹16 Cr | ₹8.39 Cr | ₹9.81 Cr | ₹7.66 Cr | ₹6.28 Cr |
Cash and Bank | ₹61 Cr | ₹15 Cr | ₹8.31 Cr | ₹1.07 Cr | ₹0.91 Cr |
Cash in hand | ₹0.48 Cr | ₹0.56 Cr | ₹0.32 Cr | ₹0.19 Cr | ₹0.19 Cr |
Balances at Bank | ₹53 Cr | ₹15 Cr | ₹7.99 Cr | ₹0.88 Cr | ₹0.65 Cr |
Other cash and bank balances | ₹7.54 Cr | - | - | - | ₹0.07 Cr |
Other Current Assets | ₹1.34 Cr | ₹1.01 Cr | ₹0.60 Cr | ₹1.16 Cr | ₹2.06 Cr |
Interest accrued on Investments | - | - | - | - | - |
Interest accrued on Debentures | - | - | - | - | - |
Deposits with Government | - | - | - | - | - |
Interest accrued and or due on loans | ₹0.09 Cr | ₹0.02 Cr | ₹0.03 Cr | ₹0.07 Cr | ₹0.03 Cr |
Prepaid Expenses | ₹0.35 Cr | ₹0.24 Cr | ₹0.10 Cr | ₹0.13 Cr | ₹0.08 Cr |
Other current_assets | ₹0.91 Cr | ₹0.74 Cr | ₹0.47 Cr | ₹0.96 Cr | ₹1.95 Cr |
Short Term Loans and Advances | ₹57 Cr | ₹7.50 Cr | ₹19 Cr | ₹21 Cr | ₹18 Cr |
Advances recoverable in cash or in kind | ₹13 Cr | ₹4.78 Cr | ₹17 Cr | ₹18 Cr | ₹16 Cr |
Advance income tax and TDS | ₹0.16 Cr | ₹0.02 Cr | - | - | - |
Amounts due from directors | - | - | - | - | - |
Due From Subsidiaries | - | - | - | - | - |
Inter corporate deposits | ₹39 Cr | - | - | - | - |
Corporate Deposits | - | - | - | - | - |
Other Loans & Advances | ₹4.48 Cr | ₹2.71 Cr | ₹2.45 Cr | ₹3.01 Cr | ₹2.72 Cr |
Total Current Assets | ₹162 Cr | ₹49 Cr | ₹47 Cr | ₹36 Cr | ₹35 Cr |
Net Current Assets (Including Current Investments) | ₹122 Cr | ₹19 Cr | ₹23 Cr | ₹17 Cr | ₹14 Cr |
Miscellaneous Expenses not written off | - | - | - | - | - |
Total Assets | ₹230 Cr | ₹132 Cr | ₹68 Cr | ₹59 Cr | ₹57 Cr |
Contingent Liabilities | - | - | ₹0.74 Cr | ₹1.70 Cr | ₹1.60 Cr |
Total Debt | ₹19 Cr | ₹17 Cr | ₹10 Cr | ₹7.36 Cr | ₹4.98 Cr |
Book Value | 7.24 | 4.53 | 3.46 | 3.14 | 2.82 |
Adjusted Book Value | 7.24 | 4.53 | 3.30 | 2.99 | 2.69 |
Compare Balance Sheet of peers of GENNEX LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GENNEX LABORATORIES | ₹434.1 Cr | 1.1% | -7.3% | 19.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹431,544.0 Cr | 2.8% | -2.7% | 50.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹164,865.0 Cr | 3.5% | 5.4% | 67.6% | Stock Analytics | |
CIPLA | ₹123,920.0 Cr | 2.9% | -1.2% | 25.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹102,224.0 Cr | 2.1% | -3.9% | 6.9% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹98,832.3 Cr | 3.3% | -2% | 53.5% | Stock Analytics |
GENNEX LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GENNEX LABORATORIES | 1.1% |
-7.3% |
19.2% |
SENSEX | 1.1% |
1.1% |
22.2% |
You may also like the below Video Courses